We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current IMPL market cap is 5.72M. The company's latest EPS is USD -4.4784 and P/E is -0.05.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 3.08M | 5.01M | 4.37M | 6.58M | 5.02M |
| Operating Income | -21.24M | -18.24M | -24.44M | -16.1M | -12.81M |
| Net Income | -31.1M | -23.04M | -30.07M | -7.36M | -13.81M |
| Year End 31 December 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 668k | 12.65M |
| Operating Income | -41.57M | -45.33M | -71.49M | -83.18M |
| Net Income | -41.86M | -45.8M | -76.54M | -106.31M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 105.17M | 88.55M | 64.73M | 44.81M | 35.07M |
| Total Liabilities | 127.46M | 132.71M | 137.63M | 123.97M | 126.98M |
| Total Equity | -22.29M | -44.16M | -72.91M | -79.16M | -91.91M |
| Year End 31 December 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 42.27M | 12.06M | 97.91M | 88.55M |
| Total Liabilities | 8.32M | 18.52M | 45.4M | 132.71M |
| Total Equity | -91.7M | -133.5M | 52.51M | -44.16M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -75.66M | -93.64M | -24.14M | -44.58M | -61.11M |
| Investing | -365k | -1.38M | -1.05M | -914k | -1.87M |
| Financing | 67.54M | 67.46M | N/A | 5k | 7.07M |
| Year End 31 December 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -36.49M | -39.18M | -66.36M | -93.64M |
| Investing | -1.52M | -1.78M | -408k | -1.38M |
| Financing | 21k | 11.06M | 147.89M | 67.46M |
| Market Cap | 5.72M |
| Price to Earnings Ratio | -0.05 |
| Price to Sales Ratio | 0.45 |
| Price to Cash Ratio | 0.09 |
| Price to Book Ratio | -0.13 |
| Dividend Yield | - |
| Shares Outstanding | 23.74M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -85.39% |
| 52 Week High | 2.87 |
| 52 Week Low | 0.19 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Impel Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
